ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,265.31
1.76%
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs Yen
153.286
-1.56%
Brent Oil
83.63
0.11%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) ニュース

AGRX Agile Therapeutics Inc

0.6022
0.00 (0.00%)
取引時間後
最終更新日： 09:00:00
15分遅延
名称 銘柄コード 市場 種別
Agile Therapeutics Inc AGRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 0.6022 09:00:00
始値 安値 高値 終値 前日終値
0.6022 0.6022
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/3/2821:05GLOBEAgile Therapeutics Reports Fourth Quarter & Full Year 2023..
2024/3/2605:30GLOBEAgile Therapeutics Announces Delisting from Nasdaq
2024/3/2119:35GLOBECorrection - Agile Therapeutics to Report Fourth Quarter and..
2024/3/2021:15GLOBEAgile Therapeutics to Report Fourth Quarter and Full Year..
2024/3/1320:31GLOBEAgile Therapeutics Completes Pay-off of Debt and Remains..
2024/2/2406:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2406:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2223:01GLOBEAgile Therapeutics Announces Exercise of Warrants for $4.8..
2024/2/1606:45EDGAR2Form 8-K - Current report
2024/2/1606:30GLOBEAgile Therapeutics Announces Extension Granted by Nasdaq..
2024/2/1410:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0806:51EDGAR2Form S-1/A - General form for registration of securities..
2024/2/0700:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0523:21EDGAR2Form S-1/A - General form for registration of securities..
2024/2/0306:27EDGAR2Form S-1/A - General form for registration of securities..
2024/1/2323:29GLOBEThe Biden-Harris Administration Announces New Guidance to..
2023/12/2022:00EDGAR2Form S-1/A - General form for registration of securities..
2023/12/1222:01GLOBEAgile Therapeutics Provides Update on Actions Being Taken to..
2023/12/1207:30EDGAR2Form S-1 - General form for registration of securities under..
2023/12/0622:00EDGAR2Form 8-K - Current report
2023/12/0422:00EDGAR2Form 8-K - Current report
2023/11/1006:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0922:15EDGAR2Form 8-K - Current report
2023/11/0922:05GLOBEAgile Therapeutics Reports Third Quarter 2023 Financial..
2023/10/2621:05GLOBEAgile Therapeutics to Report Third Quarter 2023 Financial..
2023/10/0505:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:30GLOBEAgile Therapeutics Reports an Inducement Grant to New Chief..
2023/10/0305:30EDGAR2Form 8-K - Current report
2023/9/2905:50EDGAR2Form 8-K - Current report
2023/9/0521:05GLOBEAgile Therapeutics to Present at the H.C. Wainwright 25th..
2023/8/2605:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/2221:30EDGAR2Form 8-K/A - Current report: [Amend]
2023/8/1005:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0921:10EDGAR2Form 8-K - Current report
2023/8/0921:05GLOBEAgile Therapeutics Reports Second Quarter 2023 Financial..
2023/7/2621:30GLOBEAgile Therapeutics to Report Second Quarter 2023 Financial..
2023/7/0105:50EDGAR2Form 8-K - Current report
2023/7/0105:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0105:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0105:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0105:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0105:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/2621:01GLOBEAgile Therapeutics Announces the Availability of Twirla® to..
2023/6/2401:05GLOBEAgile Therapeutics Commends the Biden Administration’s..
2023/6/1605:05GLOBEAgile Therapeutics Announces the Availability of Twirla®..
2023/6/1405:05GLOBEAgile Therapeutics Announces New Agreement with vitaCare®..
2023/5/2605:05GLOBEAgile Therapeutics Announces Closing of $7.5 Million Public..
2023/5/2309:00GLOBEAgile Therapeutics Announces Pricing of $7.5 Million Public..
2023/5/1205:05GLOBEAgile Therapeutics Reports First Quarter 2023 Financial..
2023/5/0821:00GLOBEAgile Therapeutics to Report First Quarter 2023 Financial..

最近閲覧した銘柄

NASDAQ
AGRX
Agile Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有